Board Meeting on May 27 to Consider FY26 Results & Final Dividend
Medicamen Biotech Limited · MEDICAMEQ · NSE ·
A Board Meeting is scheduled for <b>27-May-2026</b>. The agenda includes the approval of Audited Financial Results for the year ended 31-Mar-2026. The Board will also consider a proposal for the recommendation of a <b>Final Dividend</b> for the financial year 2025-2026.